← Eichor
Study identifier: NCT07192367 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder

Condition: Social Anxiety Disorder  ·  Sponsor: Emine Kanmaz

PhasePhase 4
Planned participants56
Who can joinAll sexes, 12 Years to 17 Years
Healthy volunteersNo

About this study

This study compares two treatment approaches for adolescents and young adults with social anxiety. One group will participate in therapy sessions using a virtual reality headset, while the other group will receive sertraline, a commonly used medication for social anxiety. The goal is to see which treatment is more effective in reducing anxiety symptoms and improving daily functioning. The study will also look at how acceptable and safe these treatments are. A total of 56 participants will be enrolled at Kocaeli University, Department of Child and Adolescent Psychiatry.

This description comes directly from the study's public registry record.

Talk to the study team

Emine Kayış, MD  ·  +905557452890  ·  eminekanmaz@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kocaeli University Hospital - Department of Child and Adolescent PsychiatryKocaeli, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07192367